The coming of age of Heart in a Dish
Posted on August 19, 2013
By: Ashish Mehta, Senior Research Scientist; Chrishan Ramachandra, Research Fellow; Winston Shim, Scientific Director, R&D Unit
National Heart Centre, Singapore
Introduction Drug attrition is a weaning cycle that all pharmaceutical entities navigate through in their transition paths from the developmental and pre-clinical stages to the market. Over the past few decades, a trickling of therapeutic compounds entering the drug developmental pipeline coupled w...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
cardiomyocytes, Human Pluripotent Stem Cells, induced pluripotent stem cells (iPSCs), National Heart Centre - Singapore
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
